← All Relay Therapeutics, INC filings

Relay Therapeutics, INC DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

NASDAQ
RLAY
Relay Therapeutics, INC
DEFA14A: Relay Therapeutics Sets Date for 2025 Annual Stockholders Meeting
Relay Therapeutics announces its annual stockholders meeting to be held on June 6, 2025, covering director elections, executive compensation, and auditor ratification.
NASDAQ
RLAY
Relay Therapeutics, INC
DEF: Relay Therapeutics Sets Date for 2025 Annual Stockholders Meeting
Relay Therapeutics will hold its 2025 Annual Meeting of Stockholders virtually on June 6, 2025, to elect directors, vote on executive compensation, and ratify the appointment of its independent accounting firm.
NASDAQ
RLAY
Relay Therapeutics, INC
DEFA14A: Relay Therapeutics Sets Date for Annual Stockholders Meeting, Outlines Key Proposals
Relay Therapeutics will hold its annual stockholders meeting on June 3, 2024, to elect directors, vote on executive compensation, and ratify the appointment of Ernst & Young LLP as the company's auditor.
NASDAQ
RLAY
Relay Therapeutics, INC
DEF 14A: Relay Therapeutics Announces 2024 Annual Meeting of Stockholders
Relay Therapeutics will hold its 2024 Annual Meeting of Stockholders virtually on June 3, 2024, to elect directors, vote on executive compensation, and ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm.